AGNG

Aging Population ETF

Reasons to Consider AGNG

Long-Term Growth Potential

Humans are living longer than ever, with forecasts suggesting the global population of adults age 60+ could double to more than 2bn by 2050.¹

Demographics Drive Consumption

With a ballooning senior population, particularly in western countries, we expect to see waves of innovation catering to seniors' distinct consumer preferences.

Unconstrained Approach

The Aging Population theme is a global trend, affecting a wide range of industries. AGNG invests accordingly, offering exposure to companies regardless of sector or geographic classification.

¹WHO, Oct 2022

Key Information As of 11/22/24

Inception Date	05/09/16
Total Expense Ratio	0.50%
Net Assets	$60.35 million
NAV	$31.11
Fact Sheet	View the document

ETF Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

ETF Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Trading Details As of 11/21/24

Ticker	AGNG
Bloomberg Index Ticker	ILNGRNT
CUSIP	37954Y772
ISIN	US37954Y7720
Primary Exchange	Nasdaq
Shares Outstanding	1,940,000
Number of Holdings	83
30-Day Median Bid-Ask Spread	0.37%

Distributions As of 11/22/24

30-Day SEC Yield	0.95%
Distribution Frequency	Semi-Annually

ETF Prices As of 11/22/24

NAV	$31.11	Daily Change	$0.14	0.45%
Market Price	$31.12	Daily Change	$0.14	0.45%

As of recent (09/30/24) As of recent (09/30/24)	Fund NAV	Market Price	Index
1 Year	26.40%	27.20%	26.83%
3 Years	4.73%	5.07%	5.01%
5 Years	9.83%	9.72%	10.10%
Since Inception	10.37%	10.67%	10.66%
1 Year	29.26%	29.44%	29.78%
3 Years	3.48%	3.48%	3.76%
5 Years	8.10%	8.03%	8.38%
Since Inception	9.95%	10.23%	10.25%
Year-to-Date	15.27%	15.84%	15.54%
1 Month	-1.21%	-1.03%	-1.16%
3 Months	8.95%	9.14%	9.11%
Since Inception	128.99%	134.39%	134.20%
Year-to-Date	12.59%	12.94%	12.93%
1 Month	-2.32%	-2.50%	-2.26%
3 Months	2.96%	2.93%	3.10%
Since Inception	123.68%	128.54%	128.91%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Net Assets (%)	Ticker	Name	SEDOL	Market Price ($)	Shares Held	Market Value ($)
4.33	WELL	WELLTOWER INC	BYVYHH4	137.91	18,936	2,611,463.76
3.71	BSX	BOSTON SCIENTIFIC CORP	2113434	90.00	24,856	2,237,040.00
3.40	BMY	BRISTOL-MYERS SQUIBB CO	2126335	58.87	34,833	2,050,618.71
3.36	4519 JP	CHUGAI PHARMA CO	6196408	40.48	50,049	2,025,804.40
3.15	SYK	STRYKER CORP	2853688	384.85	4,941	1,901,543.85
3.13	UCB BB	UCB SA	5596991	187.38	10,075	1,887,862.92
3.09	AMGN	AMGEN INC	2023607	294.53	6,337	1,866,436.61
3.00	ABBV	ABBVIE INC	B92SR70	176.95	10,214	1,807,367.30
2.98	MDT	MEDTRONIC PLC	BTN1Y11	86.21	20,823	1,795,150.83
2.96	ALC SW	ALCON INC	BJT1GR5	85.80	20,840	1,787,984.56
2.96	JNJ	JOHNSON & JOHNSON	2475833	155.17	11,499	1,784,299.83
2.79	LLY	ELI LILLY & CO	2516152	748.01	2,253	1,685,266.53
2.75	RO SW	ROCHE HOLDING AG-BR	7108918	301.65	5,509	1,661,791.78
2.68	AZN	ASTRAZENECA PLC-SPONS ADR	2989044	65.63	24,637	1,616,926.31
2.53	4543 JP	TERUMO CORP	6885074	19.84	77,093	1,529,368.25
2.38	NOVOB DC	NOVO NORDISK A/S-B	BP6KMJ1	104.81	13,712	1,437,193.38
2.30	068270 KS	CELLTRION INC	B0C5YV1	123.77	11,224	1,389,138.64
2.27	REGN	REGENERON PHARMACEUTICALS	2730190	738.00	1,859	1,371,942.00
2.19	VTR	VENTAS INC	2927925	63.55	20,767	1,319,742.85
2.18	EW	EDWARDS LIFESCIENCES CORP	2567116	70.48	18,686	1,316,989.28
1.93	ZBH	ZIMMER BIOMET HO	2783815	110.22	10,581	1,166,237.82
1.78	SOON SW	SONOVA HOLDING AG-REG	7156036	349.20	3,078	1,074,846.21
1.70	STMN SW	STRAUMANN HOLDING AG-REG	BQ7ZV06	124.76	8,218	1,025,238.60
1.67	SDZ SW	SANDOZ GROUP AG	BLPLD38	45.43	22,230	1,009,832.73
1.57	PODD	INSULET CORP	B1XGNW4	262.93	3,612	949,703.16
1.56	4503 JP	ASTELLAS PHARMA INC	6985383	10.08	93,490	942,715.73
1.56	BGNE	BEIGENE LTD-ADR	BYYWPW6	190.51	4,941	941,309.91
1.50	UTHR	UNITED THERAPEUTICS CORP	2430412	372.89	2,427	905,004.03
1.48	DXCM	DEXCOM INC	B0796X4	72.83	12,228	890,565.24
1.38	INCY	INCYTE CORP	2471950	71.72	11,578	830,374.16
1.24	DVA	DAVITA INC	2898087	165.51	4,522	748,436.22
1.21	3692 HK	HANSOH PHARMACEU	BJYKB72	2.38	306,643	729,497.47
1.17	GMAB DC	GENMAB A/S	4595739	207.07	3,413	706,734.25
1.11	FME GR	FRESENIUS MEDICAL CARE AG	5129074	43.98	15,158	666,686.27
1.08	COH AU	COCHLEAR LTD	6211798	193.66	3,379	654,363.10
1.07	NBIX	NEUROCRINE BIOSC	2623911	125.65	5,129	644,458.85
0.93	SN/ LN	SMITH & NEPHEW PLC	0922320	12.36	45,171	558,321.87
0.92	EXEL	EXELIXIS INC	2576941	35.61	15,584	554,946.24
0.84	OHI	OMEGA HEALTHCARE	2043274	40.11	12,658	507,712.38
0.82	EXAS	EXACT SCIENCES CORP	2719951	52.91	9,372	495,872.52
0.77	TFX	TELEFLEX INC	2881407	191.71	2,426	465,088.46
0.73	PHM SM	PHARMA MAR SA	BMW2GT8	76.51	5,746	439,648.76
0.71	DEMANT DC	DEMANT A/S	BZ01RF1	37.16	11,536	428,642.86
0.71	ENSG	ENSIGN GROUP INC/THE	B1YWPP8	146.36	2,912	426,200.32
0.61	GKOS	GLAUKOS CORP	BYMWL19	144.00	2,543	366,192.00
0.53	HALO	HALOZYME THERAPEUTICS INC	2975098	49.00	6,535	320,215.00
0.52	MMSI	MERIT MEDICAL SYSTEMS INC	2580555	105.33	2,981	313,988.73
0.51	AGIO	AGIOS PHARMACEUTICALS INC	BCBVTX1	55.68	5,559	309,525.12
0.49	BPMC	BLUEPRINT MEDICINES CORP	BWY52P3	94.15	3,149	296,478.35
0.47	AMP IM	AMPLIFON SPA	B14NJ71	24.19	11,660	282,089.92
0.47	YPSN SW	YPSOMED HOLDING AG-REG	B02SWN8	399.44	703	280,806.71
0.45	MNKD	MANNKIND CORP	BF081J4	6.84	39,575	270,693.00
0.40	NHC	NATIONAL HEALTHCARE CORP	2139731	126.48	1,895	239,679.60
0.39	ITGR	INTEGER HOLDINGS CORP	BD06LM7	138.11	1,721	237,687.31
0.38	SBRA	SABRA HEALTH CAR	B5NLBP6	18.41	12,344	227,253.04
0.37	NHI	NATL HEALTH INVESTORS INC	2626125	77.71	2,889	224,504.19
0.36	DNLI	DENALI THERAPEUTICS INC	BD2B4V0	24.69	8,880	219,247.20
0.35	NVCR	NOVOCURE LTD	BYSS4X4	17.73	12,048	213,611.04
0.35	EMBC	EMBECTA CORP	BMXWYR1	13.82	15,456	213,601.92
0.35	SIA CN	SIENNA SENIOR LIVING INC	BWTYXH4	12.05	17,539	211,293.60
0.35	CSH-U CN	CHARTWELL RETIRE	B8S8C94	11.27	18,561	209,265.20
0.34	LTC	LTC PROPERTIES INC	2498788	38.87	5,290	205,622.30
0.31	RYM NZ	RYMAN HEALTHCARE LTD	6161525	2.94	63,184	185,879.68
0.31	8086 JP	NIPRO CORP	6641599	8.97	20,649	185,288.47
0.30	TBPH	THERAVANCE BIOPHARMA INC	BMNDK09	9.47	19,038	180,289.86
0.28	AMED	AMEDISYS INC	2024332	90.64	1,844	167,140.16
0.27	AED BB	AEDIFICA	B1G5XP1	59.65	2,731	162,903.05
0.27	LIVN	LIVANOVA PLC	BYMT0J1	51.32	3,144	161,350.08
0.27	853 HK	MICROPORT SCIENTIFIC CORP	B676TW7	0.73	219,602	160,790.69
0.27	ACAD	ACADIA PHARMACEU	2713317	16.37	9,776	160,033.12
0.26	1789 HK	AK MEDICAL HOLDINGS LTD	BFD6SZ0	0.64	248,389	158,895.45
0.26	2186 HK	LUYE PHARMA GROUP LTD	BNQ4GF3	0.33	472,624	154,812.39
0.24	GN DC	GN STORE NORD A/S	4501093	18.84	7,771	146,380.12
0.23	BKD	BROOKDALE SR	B0PZN33	5.48	25,533	139,920.84
0.23	1302 HK	LIFETECH SCIENTIFIC CORP	BV9FKS0	0.18	746,392	137,104.83
0.22	EKTAB SS	ELEKTA AB-B SHS	B0M42T2	5.71	23,276	132,921.45
0.20	ATEC	ALPHATEC HOLDINGS INC	BD60BG7	10.06	12,139	122,118.34
0.18	ALEC	ALECTOR INC	BJ4LDC4	3.94	27,243	107,337.42
0.18		OTHER PAYABLE & RECEIVABLES		1.00	105,998	105,998.25
0.12	145720 KS	DENTIUM CO LTD	BF07GJ6	39.95	1,801	71,944.93
0.11	9229 JP	SUNWELS CO LTD	BNTYNB5	6.44	10,679	68,801.15
0.10	AGL	AGILON HEALTH INC	BLR4TK4	1.89	31,921	60,330.69
0.08	2500 HK	VENUS MEDTECH -H	BL6V047	0.47	102,940	48,304.05
0.07		CASH		1.00	41,225	41,225.20
0.00		RADIUS HEALTH INC - CVR	2KFF9T0	0.00	19,104	0.02
0.00		CANADIAN DOLLAR		1.00	0	-0.01
0.00		DANISH KRONE		0.14	-308	-42.99

Holdings are subject to change. "Cash" denotes U.S. dollars.

Exposure As of 10/31/24

	Sector	Weight (%)
	Health Care	91.6
	Real Estate	8.4

Source: new windowAltaVista Research, LLC

	Industry	Weight (%)
	Pharmaceuticals, Biotechnology & Life Sciences	48.1
	Health Care Equipment & Services	38.6
	Equity Real Estate Investment Trusts (REITs)	8.4
	Pharmaceuticals, Biotechnology	4.9

Source: new windowAltaVista Research, LLC

	Country	Weight (%)
	United States	53.1
	Switzerland	11.9
	Japan	8.4
	Denmark	4.7
	Britain	4.3
	China	4.0
	Belgium	3.4
	Ireland	3.0
	South Korea	2.5
	Australia	1.0
	Germany	1.0
	Other	2.7

Source: new windowAltaVista Research, LLC

All Sector, Industry and Geographic breakdowns, where provided, are based on equity positions held by the ETF and exclude cash, currencies, and other holdings.

ETF Characteristics As of 11/22/24

Return on Equity	13.10%
Weighted Avg. Market Cap	106,765 M
	2023	2024
Price-to-earnings	26.48	26.19
Price-to-book value	3.56	3.30

Source: new windowAltaVista Research, LLC

ETF Risk Stats As of 10/31/24

Versus	Beta
S&P 500	0.74
NASDAQ-100	0.48
MSCI EAFE	0.77
MSCI Emg. Mkts	0.52
Standard Deviation	16.10%

Source: new windowAltaVista Research, LLC

ETF Research

ETF Documents

Latest Premium / Discount As of 11/22/24

NAV	$31.11
Market Price	$31.12
Premium / (Discount)	$0.02

Current View 2024 Q4 As of 11/22/24

Days at Premium	29
Days at NAV	0
Days at Discount	10
Greatest Premium	0.61%
Greatest Discount	-0.51%

Daily Premium / Discount History As of 11/22/24

Hover over the chart points for details

View Chart Explanation

Download Chart Data (.CSV)

How can the Fund trade at a premium/discount to its NAV?

The primary explanation is that timing discrepancies can arise between the NAV and the trading price of the Fund. Since shares of the Fund trade on the open market, prices are affected by the constant flow of information received by investors, corporations and financial institutions. Depending on how this changing information affects investor sentiment, shares of the Fund may deviate slightly from the value of the Fund's underlying assets. The NAV of the Fund is only calculated once a day (normally at 4:00 p.m. eastern time). As a result, shareholders may pay more than NAV when they buy Fund shares and receive less than NAV when they sell those shares, because shares are purchased and sold at current market prices. However, due to the creation and redemption process that is unique to ETFs, market makers are able to minimize these deviations from NAV by taking advantage of arbitrage opportunities.

What causes these time discrepancies?

Close of Trading Times. Although both the NAV and the daily market price of the Fund are generally calculated based on prices at the closing time of the exchange (generally 4:00 p.m. eastern time), slight differences in this timing may cause discrepancies.

Time of Last Trade. Trading of Global X funds generally takes place during normal trading hours (9:30 a.m. to 4:00 p.m. eastern time). However, it is important to note that the last trade - from which the closing price is determined - may not occur at exactly 4:00 p.m. eastern time. Therefore, changing market sentiment during the time difference may cause the NAV to deviate from the closing price.

International Holdings. The premiums and discounts for funds with significant holdings in international markets may be less accurate due to the different closing times of various international markets. Because the Funds trade during U.S. market hours while the underlying securities may not, the time lapse between the markets can result in differences between the NAV and the trading price.

Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.

AGNG

Aging Population ETF

Reasons to Consider AGNG

Long-Term Growth Potential

Demographics Drive Consumption

Unconstrained Approach

Key Information As of 11/22/24

ETF Summary

ETF Objective

Trading Details As of 11/21/24

Distributions As of 11/22/24

ETF Prices As of 11/22/24

Performance History

Top Holdings As of 11/22/24

Exposure As of 10/31/24

ETF Characteristics As of 11/22/24

ETF Risk Stats As of 10/31/24

ETF Research

Investing in Pharma: How to Spot Leading Drug Candidates

Investing in Pharma: The Drug Lifecycle

In the Pipeline: Top Drug Candidates for FDA Approval in 2024

ETF Documents